Hindustan Aeronautics Ltd.

Similar documents
Initiating Coverage. Uflex Ltd.

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

LONG TERM SUBSCRIBE. IPO Report HINDUSTAN AERONAUTICS LTD. IPO Details. Research Analyst : Astha Jain

Hindustan Aeronautics Ltd

SUBSCRIBE to Hindustan Aeronautics Ltd. Invest with mid to long term time horizon

Hindustan Aeronautics Limited

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

HG Infra Engineering Ltd.

Indian Oil Corporation

Jamna Auto Industries

Gillette India. Institutional Equities. 1QFY18 Result Update

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Institutional Equities

Colgate-Palmolive (India)

Valuation and Outlook. Growth (%) PAT (Rs cr)

Power Plant. Future Products. Helicopters. Aircraft. System and Accessories. Avionics. IPO Report-Hindustan Aeronautics Ltd 16 th March, 2018

Dalmia Bharat Enterprises

EBITDA 5,076 3, , EBITDA

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

PSP Projects Ltd. 1 P a g e. Subscribe with Long Recommendation. Term View BACKGROUND

Punjab National Bank

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Institutional Equities

Initiating Coverage. Vaibhav Global Ltd. (VGL) BUY Back On Track Huge Potential Ahead. 1 P a g e

Robust results, TLT margins improved profitability.

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

Indian Oil Corporation

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Indostar Capital Finance Ltd.

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Phillips Carbon Black Ltd

Bata India. Institutional Equities. 1QFY19 Result Update BUY

Institutional Equities

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

IPO UPDATE Hindustan Aeronautics Limited

Institutional Equities

Market Review: Action: Nifty has an immediate resistance at and on a decisive close above expect rise to 11740/11770 levels.

Market Review: Action: Nifty has an immediate resistance placed at and on a decisive close above expect rise to 11540/11570 levels.

Bharat Dynamics Ltd SUBSCRIBE. Issue Open: Mar 13, 2018 Issue Close: Mar 15, IPO Note Defence. Key Financials

Techno Electric & Engineering Limited

Punjab National Bank

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

Apollo Micro Systems Ltd

Hindustan Aeronautics Limited. Hindustan Aeronautics Limited. Initial Public Offer - Note. Call Toll Free

March 15, 2018 HINDUSTAN AERONAUTICS LIMITED. SMC Ranking (3/5) About the Company. Issue Highlights. Strength. Shareholding Pattern (%)

Institutional Equities

Phillips Carbon Black Ltd

NCD ISSUE Note. Aster DM Healthcare Ltd

Institutional Equities

Honeywell Automation India Ltd

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

EBITDA 6,223 6,511 (4.4) 5, EBITDA

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Future Supply Chain Solutions Ltd

Institutional Equities

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

Margin (%) PAT (Rs cr)

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

Institutional Equities

Dabur India. Institutional Equities. 1QFY19 Result Update

Mold-Tek Packaging Limited

MISHRA DHATU NIGAM Ltd.

Performance beat on all fronts

Sandhar Technologies Limited

Pennar Industries Ltd.

Avenue Supermarts Limited

Bharat Electronics Ltd

NEUTRAL. Neogen Chemicals Ltd. Issue Open: April 24, 2019 Issue Close: April 26, IPO Note Specialty Chemicals

Newgen Software Technologies Ltd

Bajaj Electricals Ltd.

2,09,057 1,85,859 2,17, (4.1) NIM

Institutional Equities

Investment Rationale: Adj PAT (Rs cr)

Grindwell Norton Ltd

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Aster DM Healthcare Ltd

KPIT Cummins Infosystems Ltd

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Hindustan Media Ventures

Institutional Equities

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

The Ramco Cements. Institutional Equities. Event Update BUY

Bharat Financial Inclusion

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Wipro. 4QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 287. Recommendation: Hold

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

LIC Housing Finance Ltd

18,948 15,784 18, NIM

Varroc Engineering Ltd.

Transcription:

Recommendation Subscribe BACKGROUND Price Band Bidding Date Book Running Lead Manager Registrar Sector Rs.1215 Rs.1240 16-20 March SBI Capital Markets, Axis Capital Ltd Karvy Defense Capital Goods Minimum Retail Application- Detail At Cut off Price Number of Shares 12 Minimum Application Money Rs. 14,580 Discount to retail Payment Mode Rs. 25 per share Consolidated Financials (Rs Cr) FY16 FY17 ASBA Total Income 16759 17952 EBITDA 3519 4068 PAT 2004 2625 Lower Upper Valuations Band Band Market Cap (Rs Cr) 40628 41464 EPS* 78.5 78.5 P/E Ratio* 15.5 15.8 EV/ EBITDA* 7.6 7.8 Enterprise Value (Rs Cr) 30868 31704 *calculated on FY17 Post Issue Shareholding Pattern Promoters 89.8% Institutions 5.0% Bodies Corporates & Public 5.2% Offer structure for different categories QIB (Including Mutual Fund) 50% Non-Institutional Investors 15% Retail 35% Post Issue Equity (Rs. in cr) 361.5 Issue Size (Rs in cr) 4144-4229 Face Value (Rs) 10 Jehan Bhadha (+91 22 6273 8174) Research Analyst jehankersi.bhadha@nirmalbang.com Hindustan Aeronautics Limited (HAL) is the largest Defence Public Sector Undertakings ( DPSU ) in terms of value of production. HAL is engaged in design, development, manufacture, repair, overhaul, upgrade and servicing of a wide range of products including Aircraft, Helicopters, Aero-Engines, Avionics, Accessories and Aerospace Structures. HAL relies on indigenous R&D as well as on technology transfer and license agreements to manufacture their products. HAL has a sustained track record of profitability and has paid dividends every year for over 4 decades. As of December 31, 2017, the order book stood at Rs.68,461 Cr (3.8x FY17 Sales). Details and Objects of the Issue The entire public issue consists of offer for sale of Rs. 4229 Cr by the GoI. Investment Rationale: Leadership position in the Indian aeronautical industry Rising mix of fast growing Services business Expansion into engines, UAVs, civil aircrafts and exports Proven design and development capabilities Strong financial track record with robust order book position Valuation and Recommendation HAL is the largest defense PSU and the only one to manufacture defense aircrafts and helicopters. It thus faces no competition domestically and only from international players. HAL has the following positives in its favor - wide portfolio comprising of indigenous and licensed products, rising share of the fast growing services business (40% mix today from 21% in FY15), long credible history of proven design and development capabilities, expansion and diversification into new growth areas of engines, UAVs, civil aircrafts and exports, strong balance sheet and a robust order book to sales of 3.8x. HAL is being offered at a valuation at PE of 15.8x FY17 (vs. domestic peer average of 22.6x) and EV/EBITDA of 7.8x FY17 (vs. domestic peer average of 16.1x). Thus based on the business capabilities, industry growth prospects and valuations, we believe HAL is attractively priced and recommend subscribing to the issue. Financial Snapshot FY15 FY16 FY17 H1FY18 Net Revenues 15648 16759 17952 5173 Growth 7% 7% EBIDTA 3048 3519 4068 830 EBITDA Margins 19.5% 21.0% 22.7% 16.1% PAT 994 2004 2625 391 Growth 102% 31% ROCE 11.0% 27.9% 25.8% EV/EBIDTA @ Rs 1240 7.8 P/E @ Rs 1240 15.8 P/BV @ Rs 1240 3.3 Source: Company data, NB Research H1:H2 mix in HAL s case is ~25:75; to that extent, annualizing the numbers shall not give the right perspective. 1

Investment Rationale Leadership position in the Indian aeronautical industry with strong GoI support HAL is the largest Defence Public Sector Undertakings ( DPSU ) in terms of value of production in the Indian defence sector according to the MoD. They have their longstanding relationships, particularly with the Indian Defence Services and the DRDO as well as with various academic institutions and regulatory agencies. They have also developed a deep knowledge base and understanding of the aeronautical industry, particularly in India. The GoI is the promoter of the company and HAL derives a substantial portion of their revenue from the Indian Defence Services (93% of sales in FY17). HAL has cultivated a relationship of trust and reliability with their customers, including the GoI and the Indian Defence Services which allows HAL to understand their requirements and generate products and services which are responsive to their demands. Diversified product portfolio HAL s products portfolio includes fighter aircraft, trainer aircraft, transport aircraft, military helicopter and civil helicopters and their engines, avionics and accessories (such as special test equipment and ground handling equipment and ground support equipment), which are both indigenously designed or manufactured under license. INDIGENOUS PRODUCTS (~2/3 rd of product sales) Light Combat Aircraft Tejas Jaguar DARIN-III Upgrade Mirage 2000 Upgrade ALH Dhruv ALH MkIV Rudra Cheetal Light Combat Helicopter LICENSED PRODUCTS (~1/3 rd of product sales) Sukhoi Su-30 MKI Dornier-228 Hawk Mk-132 Aircraft Cheetah Chetak Lancer Source: Company 2

Rising share of Services revenues augurs well for future growth visibility due to its counter cyclical nature HAL intends to increase its presence in the high value services market, given its countercyclical nature and opportunities for sustained growth. They intend to leverage the opportunities arising from the rapid expansion of the defense fleet. As a result, HAL has developed a wide range of value added and customised services that customers can select. FY15 FY16 FY17 H1FY18 Product Revenue 12194 12892 12393 3049 Growth 6% -4% Mix in total revenue 78% 75% 67% 58% Service Revenue 3345 4095 5816 2114 Growth 22% 42% Mix in total revenue 21% 24% 31% 40% Others 109 172 346 114 Total Gross Revenue 15648 17159 18555 5277 Growth 10% 8% Source: Company, NB Research Tejas to be an important growth driver for HAL The Light Combat Aircraft ("LCA", also known as Tejas) is a single-engine, light weight and multi-role supersonic fighter. It has a quadruplex digital fly-by-wire flight control system with associated advanced flight control features. The aircraft, with its delta wing, is designed for air combat and offensive air support with reconnaissance. Currently, HAL has capacity to manufacture 8 Tejas LCAs per annum which is slated to increase to 16 shortly, which would propel growth for HAL. (The approximate cost of a Tejas Mark I aircraft is ~Rs. 160 Cr and that of Tejas Mark IA is ~Rs. 240 Cr). Expansion and diversification into new growth areas of engines, UAVs, civil aircrafts and exports In order to meet the demand for aircraft and helicopter engines, HAL has initiated the indigenous design and development of the Hindustan Turbo Fan Engine ( HTFE-25 ), a 25 kn thrust class turbofan engine, and the Hindustan Turbo Shaft Engine ("HTSE-1200"), a 1,200 KW shaft power engine. In addition, they have initiated the indigenous design and development of a mini UAV (Unmanned Aerial Vehicle) of the 8 kilograms class to meet the emerging requirements of military, paramilitary, police and civil sectors, and intend to subsequently enter into the market of larger UAVs with the Rustom-II medium-altitude, long-endurance UAV which they are jointly developing with the Aeronautical Development Establishment (ADE). Moreover, given the growth in civil aviation in India, an opportunity exists for them to position the Dornier Do-228 aircraft for civil application. As the development of their indigenous aircraft and helicopter platforms continue to progress and mature, HAL also intends to expand their export sales of these products as well as aerostructures, avionics, spares and services in international markets. 3

Proven design and development capabilities HAL has 11 dedicated R&D Centres and these R&D Centres are capable of developing a wide range of products, upgrading products with combat operational capability and operational performance and maintaining a pipeline of products to meet their future needs. These R&D Centres have facilities for research and prototype activities and are co-located with their production divisions to provide effective concurrent manufacturing, design and development support. Their design capabilities provide them with a significant competitive advantage in the Indian aeronautical industry. The R&D Centres are approved by, among others, the Department of Scientific and Industrial Research and the Centre for Military Airworthiness and Certification (CEMILAC). HAL conducts research, design and development activities under customer funded contracts as well as their own independent funds. For H1FY18 and FY17 and FY16, the research, design and development expenses were Rs. 510 Cr, Rs. 1,284 Cr and Rs. 1,191 Cr, respectively, which accounted for 9.7%, 6.9 % and 6.9%, respectively of their revenue from operations. Strong financial track record with robust order book position HAL has demonstrated a strong financial track record. As of September 30, 2017, HAL had cash and cash equivalents of Rs.11,699 Cr. The company has grown its net sales and operating profits at a CAGR of 7% and 16% respectively over FY15-17 and generated an average ROCE of 27% over the same period. As of December 31, 2017, HAL s order book stood at Rs.68,461 Cr (3.8x FY17 sales) thus providing strong visibility of earnings growth in coming years. Concerns Competitive intensity to rise in the long run GoI is encouraging private companies to enter and participate in defense contracts. In May 2017, the Government has introduced a strategic partnership model under DPP 2016 (the "DPP Strategic Partnership Model") under which the GoI seeks to identify a few Indian private companies as strategic partners who would initially tie up with shortlisted foreign OEMs to manufacture military platforms and equipments. These policies have raised the level of competition and pose a threat to the growth of HAL, although in the long run. Tepid revenue momentum Although HAL has a robust order book of Rs. 68,461 Cr which is 3.8x its FY17 sales; we do not expect a significant acceleration in sales in coming years owing to the slow pace of execution as well as the longer delivery schedule of orders (~4 years). Over FY15-17, HAL s net sales have grown at a meager pace of 7% CAGR. 4

Valuation and Recommendation We note that HAL s capabilities in manufacturing and servicing of defense aircrafts and helicopters makes it a direct comparable to established International defense players. HAL is the largest DPSU and the only one to manufacture defense aircrafts and helicopters. It thus faces no competition domestically and only from international players. HAL has the following positives in its favor - wide portfolio comprising of indigenous and licensed products, rising share of the fast growing services business (40% mix today from 21% in FY15), long credible history of proven design and development capabilities, expansion and diversification into new growth areas of engines, UAVs, civil aircrafts and exports, strong balance sheet and a robust order book to sales of 3.8x. HAL is being offered at a valuation at PE of 15.8x FY17 (vs. domestic peer average of 22.6x) and EV/EBITDA of 7.8x FY17 (vs. domestic peer average of 16.1x). Thus based on the business capabilities, industry growth prospects and valuations, we believe HAL is attractively priced and recommend subscribing to the issue. Peer Comparison W.C / Sales Total Asset Turns EBITDA Margins ROE OB / Sales PE EV/EBITDA Sales D/E Domestic - FY17 figures in Rs Cr Bharat Electronics 8654 0.0 12% 1.9 21.7% 17.6% 4.7 23.5 18.9 Cochin Shipyard 2059 0.1-16% 0.6 18.5% 16.8% 3.9 21.6 13.3 Average 0.0-2% 1.3 20.1% 17.2% 4.3 22.6 16.1 Hindustan Aeronautics 17952 0.0 14% 2.2 15.9% 31.2% 2.2 11.3 7.9 International CY17 figures in USD Bn Lockheed Martin 51.1 NA 2% 1.1 13.9% 16.3% 2.0 26.0 15.5 Raytheon 25.4 3.1 4% 0.8 15.3% 20.2% 1.3 25.5 15.0 BAE Systems* 18.5 6.7 7% 0.8 10.2% 35.2% 2.1 17.1 10.5 Thales* 14.9 4.9 8% 0.7 11.7% 20.4% 2.0 21.3 9.3 Kongsberg Gruppen* 14.7 3.0-18% 0.7 8.4% 8.2% 4.3 37.6 18.5 SAAB* 3.8 3.0-22% 0.8 9.5% 11.7% 3.4 26.3 18.2 Average 4.1-3% 0.8 11.5% 18.7% 2.5 25.6 14.5 Source: Company Data, Morningstar, Nirmal Bang Research *Denotes TTM figures Note: Working Capital excludes cash and cash equivalents 5

Financials P&L (Rs. Cr) FY15 FY16 FY17 H1FY18 Balance Sheet (Rs. Cr) FY15 FY16 FY17 H1FY18 Net Revenue 15648 16759 17952 5173 Share Capital 482.0 361.5 361.5 361.5 % Growth 7% 7% Reserve & Surplus 14,362 10,671 12,198 12,582 COGS 8249 8613 9206 1961 Networth 14,844 11,032 12,559 12,944 % of Revenues 52.7% 51.4% 51.3% 37.9% Total Loans 452 477 1,394 413 Employee Cost 3281 3274 3570 1798 Long term provisions 2,573 2,483 2,030 1,921 % of Revenues 21.0% 19.5% 19.9% 34.8% Adv & Milest. Receipts 38,110 35,942 28,909 31,570 Other expenses 1070 1352 1107 583 Trade payable 2,271 2,151 1,797 2,091 % of Revenues 6.8% 8.1% 6.2% 11.3% Deferred Tax Liabilities 661 815 960 960 EBITDA 3048 3519 4068 830 Other Current Liab 1,039 994 1,026 884 EBITDA Margin 19.5% 21.0% 22.7% 16.1% Short term provisions 2,472 2,638 2,878 3,061 Provisions 2197 1051 812 352 Total Current Liab. 43,891 41,725 34,610 37,606 Depreciation 883 863 713 258 Total Equity & Liab. 62,420 56,532 51,552 53,843 Other Income 1713 1608 1059 390 Fixed Assets & CWIP 7,341 7,951 8,741 8,878 Interest 8 0 10 1 Investments in JVs 195 190 205 204 PBT 1673 3213 3592 610 Other Invests. & L&A 622 778 848 871 Tax 679 1209 967 219 Other non Curr. assets 1,730 1,888 1,578 1,871 Tax rate 41% 38% 27% 36% Bank - - - - PAT 994 2004 2625 391 Cash 17,671 13,303 11,153 11,699 Adj. PAT Margin 6.4% 12.0% 14.6% 7.6% Inventories 24,953 23,982 21,321 22,184 % Growth 102% 31% Debtors 6,051 4,837 4,221 4,265 EPS (Post Issue) 29.7 59.9 78.5 Short term Advances 176 98 99 107 Performance Ratios FY15 FY16 FY17 H1FY18 Other Current assets 3,681 3,506 3,387 3,763 EBITDA Margin (%) 19.5% 21.0% 22.7% 16.1% Total Assets 62,420 56,532 51,552 53,843 PAT Margin (%) 6.4% 12.0% 14.6% 7.6% Cash Flow (Rs. Cr) FY15 FY16 FY17 H1FY18 ROE (%) 7% 18% 21% EBITDA 3,048 3,519 4,068 830 ROCE (%) 11.0% 27.9% 25.8% Provisions & Others (580) 580 264 30 Net D/E (x) -1.2-1.2-0.8-0.9 Op. profit before WC 2,468 4,099 4,332 860 Sales Growth (%) 7% 7% Change in WC 1,514 (90) (3,700) 1,441 EBITDA Growth (%) 15% 16% Less: Tax (1,065) (861) (1,037) (384) PAT Growth (%) 102% 31% CF from operations 2,917 3,148 (405) 1,917 Turnover Ratios FY15 FY16 FY17 H1FY18 Addition to assets (917) (1,636) (1,581) (420) Debtors Days 141 105 86 (Invest.)/Maturity of Dep (10,183) 2,983 4,596 (116) Inventory Days 582 522 434 CF from Investing (11,100) 1,347 3,014 (536) Creditor Days 100 91 71 Buyback of shares - (5,266) - - Asset Turnover (x) 1.0 1.5 1.3 Loan from banks (679) - 950 (950) Valuation Ratio FY15 FY16 FY17 H1FY18 Dividend Paid (576) (614) (1,104) (0) Price/Earnings (x) 15.8 Interest paid (8) - (10) (1) EV/EBITDA (x) 7.8 CF from Financing (1,264) (5,880) (164) (951) Price/BV (x) 3.3 Net Change in cash (9,447) (1,385) 2,446 430 Mkt cap/sales (x) 2.3 Cash at beginning 27,118 14,688 8,708 11,270 EV/Sales (x) 1.8 Cash at end 17,671 13,303 11,153 11,699 Source: Company Data, Nirmal Bang Research Note: As H1:H2 mix is ~25:75, we believe annualizing the numbers shall not give the right perspective. 6

Disclosure: This Report is published by Nirmal Bang Securities Private Limited (hereinafter referred to as NBSPL ) for private circulation. NBSPL is a registered Research Analyst under SEBI (Research Analyst) Regulations, 2014 having Registration no. INH000001766. NBSPL is also a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments. It is also a registered Portfolio Manager having registration no as INP000002981. NBSPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. NBSPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in securities Market. NBSPL, its associates or analyst or his relatives do not hold any financial interest in the subject company. NBSPL or its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the subject company. NBSPL or its associates or Analyst or his relatives hold / do not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of this research report. NBSPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. NBSPL or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an officer, director or employee of Subject Company and NBSPL / analyst has not been engaged in market making activity of the subject company. Analyst Certification: I, Jehan Bhadha, the research analyst and author of this report, hereby certify that the views expressed in this research report accurately reflects my/our personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst(s) principally responsible for the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. 7

Disclaimer: This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. NBSPL is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In preparing this research, we did not take into account the investment objectives, financial situation and particular needs of the reader. This research has been prepared for the general use of the clients of NBSPL and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. NBSPL will not treat recipients as customers by virtue of their receiving this report. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject NBSPL & its group companies to registration or licensing requirements within such jurisdictions. The report is based on the information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to correct or update the information or opinions in it. NBSPL or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. NBSPL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This information is subject to change without any prior notice. NBSPL reserves its absolute discretion and right to make or refrain from making modifications and alterations to this statement from time to time. Nevertheless, NBSPL is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Before making an investment decision on the basis of this research, the reader needs to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the company nor the director or the employees of NBSPL accept any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Here it may be noted that neither NBSPL, nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in connection with the use of the information contained in this report. Copyright of this document vests exclusively with NBSPL. Our reports are also available on our website www.nirmalbang.com. Nirmal Bang Research (Division of Nirmal Bang Securities Pvt. Ltd.) B-2, 301/302, Marathon Innova, Opp. Peninsula Corporate Park, Off Ganpatrao Kadam Marg, Lower Parel (W), Mumbai-400013 Board No. : 91 22 3926 8000/8001 Fax. : 022 3926 8010 8